USPTO serial 79223783
Serial No. 79223783
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 22, 2019
- Examiner
- SHEN, ELIZABETH S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79223783?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
SHENYANG, CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
SHENYANG, CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
SHENYANG, CN
Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alex Patel
Alex Patel Patel & Almeida, P.C.16830 Ventura Blvd., Suite 360Encino, CA 91436UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vitamin preparations; Medicines for human purpose, namely, vitamins, sulfanilamides, hormones, antibiotics, antivirotics, antiallergic medicines, for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases, for dental purposes, for the treatment of uterus recovery, postpartum hemorrhage and promoting intestinal exhaust; pharmaceutical preparations for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; Chemico-pharmaceutical preparations for the treatment of stomach and intestinal diseases, respiratory tract infection diseases, angiocardiopathy and nervous diseases; drugs for medical purpose, namely, acetaminophen, antacids and antivirals; Pharmaceutical preparations, namely, drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations, namely, drug delivery agents in the form of encapsulated pills that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Raw material drugs, namely, herbal extracts, vitamins, sulfanilamides, hormones, antibiotics, antivirotics, theophylline for the treatment of uterus recovery, postpartum hemorrhage and promoting intestinal exhaust; Chemical preparations for medical purposes, namely, for the treatment of heart disease, diabetes, high blood pressure, depression, blood diseases, cancer and hepatitis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks owned by NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 8, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 8, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jan 22, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 21, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 10, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 22, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 17, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 17, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 17, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 17, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 17, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 22, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 22, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 15, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 14, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 28, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |